Found: 13
Select item for more details and to access through your institution.
Clinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examples.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2019, v. 62, n. 10, p. 673, doi. 10.1002/jlcr.3712
- By:
- Publication type:
- Article
Guidance on current good radiopharmacy practice for the small-scale preparation of radiopharmaceuticals using automated modules: a European perspective.
- Published in:
- 2014
- By:
- Publication type:
- Other
Selection of the First 99m Tc-Labelled Somatostatin Receptor Subtype 2 Antagonist for Clinical Translation—Preclinical Assessment of Two Optimized Candidates.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 1, p. 19, doi. 10.3390/ph14010019
- By:
- Publication type:
- Article
Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms.
- Published in:
- Pharmaceuticals (14248247), 2017, v. 10, n. 1, p. 30, doi. 10.3390/ph10010030
- By:
- Publication type:
- Article
Radiolabelled CCK<sub>2</sub>R Antagonists Containing PEG Linkers: Design, Synthesis and Evaluation.
- Published in:
- ChemMedChem, 2021, v. 16, n. 1, p. 155, doi. 10.1002/cmdc.202000392
- By:
- Publication type:
- Article
Superior Diagnostic Performance of the GLP-1 Receptor Agonist [Lys<sup>40</sup>(AhxHYNIC-[<sup>99m</sup>Tc]/EDDA)NH<sub>2</sub>]-Exendin-4 over Conventional Imaging Modalities for Localization of Insulinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD).
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 11, p. 2175, doi. 10.1007/s00259-014-2866-8
- By:
- Publication type:
- Article
Comparative biodistribution of 12 In-labelled gastrin/CCK2 receptor-targeting peptides.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 8, p. 1410, doi. 10.1007/s00259-011-1806-0
- By:
- Publication type:
- Article
Comparison of the binding and internalization properties of 12 DOTA-coupled and In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 8, p. 1417, doi. 10.1007/s00259-011-1816-y
- By:
- Publication type:
- Article
Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 8, p. 1426, doi. 10.1007/s00259-011-1818-9
- By:
- Publication type:
- Article
Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2021, v. 6, n. 1, p. 1, doi. 10.1186/s41181-021-00123-2
- By:
- Publication type:
- Article
EANM guideline on the validation of analytical methods for radiopharmaceuticals.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2020, v. 5, n. 1, p. 1, doi. 10.1186/s41181-019-0086-z
- By:
- Publication type:
- Article
A novel CCK<sub>2</sub>/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma: a multicenter phase I GRAN-T-MTC study.
- Published in:
- Polish Archives of Internal Medicine, 2018, v. 128, n. 12, p. 791, doi. 10.20452/pamw.4387
- By:
- Publication type:
- Article